Search research articles
Contact Us
Filters
Showing results (51-60 of 84) with videos related to
Page
of 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 1998
Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma
N L Berinstein, A J Grillo-López, C A White, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy
M S Czuczman, A J Grillo-López, P McLaughlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2000
Response criteria for NHL: importance of 'normal' lymph node size and correlations with response rates
A J Grillo-López, B D Cheson, S J Horning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy
M S Czuczman, A J Grillo-López, C A White, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 12, 2001
One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women
A L Friedlander, G E Butterfield, S Moynihan, et al.
ACS Chemical Biology
|
October 22, 2025
Development of a Real-Time Fluorescence-Based Deamination Assay and Identification of Inhibitors of Human Cytidine Deaminase
Ramkumar Moorthy, Michael J Grillo, Jordan W Baur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2000
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment
T A Davis, A J Grillo-López, C A White, et al.
Revista Espanola De Cardiologia (English Ed.)
|
July 20, 2014
Health care and nonhealth care costs in the treatment of patients with symptomatic chronic heart failure in Spain
Juan F Delgado, Juan Oliva, Miguel Llano, et al.
Current Pharmaceutical Biotechnology
|
January 5, 2002
Monoclonal antibodies: a new era in the treatment of non-Hodgkin's lymphoma
A J Grillo-López, B K Dallaire, A McClure, et al.
Current Pharmaceutical Biotechnology
|
July 27, 2001
Rituximab: the first monoclonal antibody approved for the treatment of lymphoma
A J Grillo-López, C A White, B K Dallaire, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 84) with videos related to
Sort By:
Page
of 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 1998
Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma
N L Berinstein, A J Grillo-López, C A White, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy
M S Czuczman, A J Grillo-López, P McLaughlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 10, 2000
Response criteria for NHL: importance of 'normal' lymph node size and correlations with response rates
A J Grillo-López, B D Cheson, S J Horning, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 24, 1999
Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy
M S Czuczman, A J Grillo-López, C A White, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 12, 2001
One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women
A L Friedlander, G E Butterfield, S Moynihan, et al.
ACS Chemical Biology
|
October 22, 2025
Development of a Real-Time Fluorescence-Based Deamination Assay and Identification of Inhibitors of Human Cytidine Deaminase
Ramkumar Moorthy, Michael J Grillo, Jordan W Baur, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 30, 2000
Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment
T A Davis, A J Grillo-López, C A White, et al.
Revista Espanola De Cardiologia (English Ed.)
|
July 20, 2014
Health care and nonhealth care costs in the treatment of patients with symptomatic chronic heart failure in Spain
Juan F Delgado, Juan Oliva, Miguel Llano, et al.
Current Pharmaceutical Biotechnology
|
January 5, 2002
Monoclonal antibodies: a new era in the treatment of non-Hodgkin's lymphoma
A J Grillo-López, B K Dallaire, A McClure, et al.
Current Pharmaceutical Biotechnology
|
July 27, 2001
Rituximab: the first monoclonal antibody approved for the treatment of lymphoma
A J Grillo-López, C A White, B K Dallaire, et al.
Page
of 9